Tamoxifen prevents breast cancer in high-risk women that is a selective estrogen receptor modulator (SERM). It behaves like estrogen in a few of the body's tissues, such as the uterus, and raises the risk of endometrial cancer if taken for more than two years. The chance is much increased in postmenopausal women.